'game-changing' coronavirus pill

MrDJ Member Posts: 278
edited 5. Dec 2021, 11:28 in Coronavirus (COVID-19)

The health service will reportedly deliver courses of molnupiravir, sometimes referred to as Lagevrio, to clinically vulnerable and and immunosuppressant patients within as little as 48 hours of them testing positive for COVID-19.

Game changer yes, but will it help us as you will need to have had a positive covid test first before it is prescribed?

more info:

News report from the BBC


  • Poppyjane
    Poppyjane Moderator Posts: 754

    Thanks for this post @MrDJ , I will pass this on.


    If it would be helpful to talk to someone ring the Helpline 0800 5200 520

    Monday - Friday 9.00a.m. - 6.00p.m.

  • Arthuritis
    Arthuritis Member Posts: 444
    edited 5. Dec 2021, 20:41

    @MrDJ I wouldn’t feel too bad about not having access to Molnupiravir. The FDA only gave it approval by an exceptionally narrow margin because there was no alternative home pill at the time, however there are far better ones going for approval now. Merck admitted to the FDA its only 30% effective at keeping you out of the hospital, not 50% as originally claimed. Also the method by which it works has alarmed a few infectious disease specialists (it induces a high rate of viral mutation). Both GSK & Pfizer are bringing out their own antiviral pills that work by the more traditional means of stopping viral replication enzymes. Pfizer’s Paxlovid, by the end of December. Pfizer has claimed that it is 89% effective in reducing hospital admission.

    Both GSK & Pfizer have a long track record with antivirals.9